About: Combretastatin A-1 phosphate potentiates the antitumor activity of carboplatin and paclitaxel in a severe combined immunodeficiency disease (SCID) mouse model of human ovarian carcinoma

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Combretastatin A-1 phosphate potentiates the antitumor activity of carboplatin and paclitaxel in a severe combined immunodeficiency disease (SCID) mouse model of human ovarian carcinoma Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 July 2006

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в липні 2006 (uk) im Juli 2006 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en xunetu de 2006 (ast) scientific article published on 01 July 2006 (en)
publication date	wds:Q80048628-5C8B1CB4-4CF4-4F2C-A884-88D0F77298EF
publication date	2006-07-01 00:00:00Z (xsd:dateTime)
author name string	wds:Q80048628-396F05C0-2655-4197-8314-6705A1BC52B9 wds:Q80048628-3C70907F-75C4-44FA-A90A-D6AA4A6F96DD wds:Q80048628-C23A4774-C86A-4A05-B84F-0FE908825C63 wds:Q80048628-E4E4117E-ADDA-416B-B5C5-C2E23733DDE6 wds:Q80048628-FF0E7A5C-4A97-4EA9-A54E-DFCE1EF1FA53
author name string	J Hua M Lindvall K Staflin G Honeth S Järnum
rdfs:label	Combretastatin A-1 phosphate potentiates the antitumor activity of carboplatin and paclitaxel in a severe combined immunodeficiency disease (SCID) mouse model of human ovarian carcinoma (en) Combretastatin A-1 phosphate potentiates the antitumor activity of carboplatin and paclitaxel in a severe combined immunodeficiency disease (SCID) mouse model of human ovarian carcinoma (nl)
skos:prefLabel	Combretastatin A-1 phosphate potentiates the antitumor activity of carboplatin and paclitaxel in a severe combined immunodeficiency disease (SCID) mouse model of human ovarian carcinoma (en) Combretastatin A-1 phosphate potentiates the antitumor activity of carboplatin and paclitaxel in a severe combined immunodeficiency disease (SCID) mouse model of human ovarian carcinoma (nl)
name	Combretastatin A-1 phosphate potentiates the antitumor activity of carboplatin and paclitaxel in a severe combined immunodeficiency disease (SCID) mouse model of human ovarian carcinoma (en) Combretastatin A-1 phosphate potentiates the antitumor activity of carboplatin and paclitaxel in a severe combined immunodeficiency disease (SCID) mouse model of human ovarian carcinoma (nl)
author	wds:Q80048628-F2F906EF-13E4-4300-9CD6-F67AF9864F74
author	Päivi Kannisto
title	wds:Q80048628-F35A4357-0831-4BDE-AC80-2ACECDFC8AE4
title	Combretastatin A-1 phosphate potentiates the antitumor activity of carboplatin and paclitaxel in a severe combined immunodeficiency disease (SCID) mouse model of human ovarian carcinoma (en)
page(s)	wds:Q80048628-E7127C07-96CE-488E-8112-E5EF684D431A
page(s)	1557-1564
instance of	wds:Q80048628-9F7B636B-CBA6-408D-BD1D-692DCC045775
instance of	scholarly article
main subject	wds:Q80048628-1E388D35-5749-4A36-A71C-3B96645FE09D wds:Q80048628-4B8ED871-F39A-48FF-A087-5445256F7316 wds:Q80048628-6EF1EFBA-B976-4EEA-A0EF-261157CB10CD wds:Q80048628-77768706-D45D-48EE-8D95-9B9CCCE84D9B
main subject	ovarian carcinoma wd:Q423762 carboplatin severe combined immunodeficiency
PubMed ID	wds:Q80048628-3D6146E5-4E27-42D5-AF3E-172AFAB48906
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/16884365
PubMed ID	16884365
published in	wds:Q80048628-CF743DAB-CA81-4BC6-A705-B19838257E07
published in	International Journal of Gynecological Cancer
issue	wds:Q80048628-E126F6F2-F47E-4AB4-B525-483A64CDE8F5
volume	wds:Q80048628-2389AB37-705E-490D-A076-503CCABFE878
issue	4
volume	16
DOI	wds:Q80048628-61159536-FF1E-4655-859C-02E28CFF3000
DOI	http://dx.doi.org/10.1111/J.1525-1438.2006.00627.X
DOI	10.1111/J.1525-1438.2006.00627.X
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q80048628
is cites work of	Stabilizing versus destabilizing the microtubules: a double-edge sword for an effective cancer treatment option? Tumorgrafts as in vivo surrogates for women with ovarian cancer. A Phase Ib trial of CA4P (combretastatin A-4 phosphate), carboplatin, and paclitaxel in patients with advanced cancer Patient-Derived Xenograft Models of Epithelial Ovarian Cancer for Preclinical Studies.
is cites work of	wds:Q33389126-1D33E26B-F4D9-495E-A77F-EA0DBE119B79 wds:Q26781365-8864905A-CF0A-4843-AFD3-399BA2F71B2F wds:Q37626455-3D2F8705-517B-43C8-985A-34195C771972 wds:Q38722976-DE5E6150-E017-4431-8CE3-92882754FD0B

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software